
EAU 2019

Read the full Report (pdf)
European Association of Urology
15-19 March 2019 Barcelona, Spain
Featured articles


Interview with EAU Secretary-General Prof. Chris Chapple
CONTENTS
Online First
Prostate Cancer

Barentsz Trial – Bi-parametric MRI versus multi-parametric MRI
Enzalutamide plus ADT improves outcomes for metastatic hormone-sensitive prostate cancer

Prostate cancer active surveillance: Better patient risk stratification and use of imaging
The role of pelvic lymph node dissection in prostate cancer: Extended vs standard
When to use imaging and imaging-guided therapies
Radioguided surgery is the future?
Bladder Cancer

Live surgery bladder tumour resection

Largest safety study of its kind with atezolizumab in metastatic bladder cancer

Bladder cancer risk and early detection

Consensus treatment pathway for patients with limited pelvic lymph node involvement in otherwise localised bladder cancer
FGFR3 gene mutation: Favourable prognostic impact in bladder cancer
Bladder cancer in young patients
Spanish study directly links surgical volume with mortality in bladder cancer patients undergoing cystectomy

Updated interim results of phase 2 trial of pembrolizumab for high-risk NMIBC unresponsive to BCG
Robot-assisted radical cystectomy or open radical cystectomy?
Renal Transplantation and Renal Cell Carcinoma

Focus on kidney: End of monotherapy


Andrology

Live penile implant surgery

Microdissection testicular sperm extraction (microTESE)
HPV and penile cancer

Male infertility/Premature ejaculation

Testosterone replacement therapy: Safe and maybe even protective
Focus on treatment of erectile dysfunction and Peyronie’s disease
Penile prosthesis implantation
Functional Urology
Decision aids are too difficult for patients
